Polynucleotides and skin boosters can both improve skin quality, but they are designed to do so in different ways. Polynucleotides are used to support gradual improvement in skin quality, including texture and elasticity. Hyaluronic-acid skin boosters, such as Teoxane Redensity 1, are primarily chosen to improve hydration, suppleness, radiance, and the appearance of fine dehydration lines.
Neither is automatically “better”. The more suitable option depends on whether your main concern is dehydrated-looking skin, early textural change, crepiness, reduced elasticity, sensitivity, or a broader decline in skin quality. At Clinic 22, this decision is made following an individual consultation rather than using a one-size-fits-all treatment plan.
The main difference: skin hydration versus skin-quality support
Polynucleotides are injectable preparations containing purified nucleotide chains. They are not dermal fillers and are not intended to add volume or change facial shape. Instead, they are used to support skin-quality improvement over time, with treatment plans often focusing on concerns such as reduced elasticity, fine lines, crepey texture, and fragile-looking skin, including the delicate under-eye area.
Skin boosters are a broader category of injectable skin-quality treatments. At Clinic 22, Redensity 1 is a skin booster containing non-cross-linked hyaluronic acid alongside amino acids, antioxidants, minerals, and a vitamin. Hyaluronic acid attracts and holds water, so the main aim is to improve hydration and give the skin a smoother, fresher, more supple appearance. The manufacturer’s product information explains the formulation in more detail.
There is overlap: both treatments may support improved hydration, texture, and overall skin quality. The distinction is in the treatment emphasis. A skin booster is usually the more direct choice when hydration is the primary concern, while polynucleotides may be considered when the focus is on gradual improvement in skin texture and resilience.
| Feature | Polynucleotides | Skin boosters |
|---|---|---|
| Main focus | Supporting skin quality, resilience, and texture | Improving hydration, suppleness, and radiance |
| Key ingredient type | Purified nucleotide chains | Usually hyaluronic acid; Redensity 1 also contains a nutrient complex |
| Expected change | Gradual improvement in skin quality over time | More hydrated, smoother-looking skin after a planned course |
| May suit concerns such as | Crepiness, fine lines, reduced elasticity, and delicate or stressed-looking skin | Dullness, dehydration, fine dehydration lines, and reduced glow |
| Not intended to do | Add facial volume or alter contours | Create significant volume or lift |
When polynucleotides may be considered
Polynucleotides may be worth discussing if your goal is not simply a more hydrated appearance, but gradual improvement in the way the skin looks and feels over time. They are commonly considered for areas where skin can become thin, crepey, less elastic, or tired-looking, such as the face, neck, and under-eye region.
Results should be assessed over weeks rather than immediately after treatment. A temporary post-treatment swelling effect is not the same as the eventual result; the visible aim is progressive, natural-looking improvement in skin quality rather than an instant structural change.
Clinical Note from Nurse Rhi Bell
Treatment planning at Clinic 22 is based on an individual consultation. This includes considering the area being treated, your skin concerns, medical history, previous treatments, and realistic expectations before deciding whether polynucleotides, a skin booster, another approach, or no injectable treatment is appropriate.
Research into polynucleotides in aesthetic medicine is promising, including studies reporting improvements in texture, elasticity, and wrinkle-related outcomes. However, the evidence base is still developing, with variation in the products, treatment protocols, and outcome measures studied. A systematic review of polynucleotides in aesthetic medicine concluded that larger, higher-quality studies are still needed to establish their optimal use.
When a skin booster may be considered
A skin booster may be the more relevant option when your main concern is skin that looks dehydrated, dull, or less smooth, rather than a concern about facial volume. Hyaluronic-acid skin boosters are designed to improve the skin’s moisture balance and can be useful for people who want refinement without changing their facial proportions.
This does not mean a skin booster is only for younger skin. Hydration can influence how fine lines, texture, and radiance are perceived at many stages of skin ageing. However, it will not replace treatment designed for significant volume loss, pronounced skin laxity, deep static lines, active inflammatory skin disease, or scarring.
Evidence for injectable hyaluronic acid in skin-quality improvement is also encouraging, particularly for hydration, elasticity, brightness, and texture. A systematic review of injectable hyaluronic acid found positive skin-quality outcomes, while noting the need for larger controlled trials. Results depend on the product used, treatment area, baseline skin condition, and individual response.
How to decide between polynucleotides and skin boosters
It can help to begin with the outcome you would like to see rather than the name of a treatment.
- If your skin feels dehydrated and looks dull: a skin booster may be the more direct starting point.
- If you are noticing crepiness, reduced elasticity, or increasingly fragile-looking skin: polynucleotides may be more relevant to discuss.
- If both hydration and tissue quality are concerns: the best plan may involve selecting and sequencing treatments according to your skin, priorities, and treatment timeline.
- If you want added volume, lift, or contour: neither treatment should be viewed as a substitute for a treatment specifically planned for structural facial support.
During consultation, skin quality, facial anatomy, medical history, previous aesthetic treatments, current skincare, and realistic expectations all matter. A detailed assessment also helps identify when another treatment, or no injectable treatment at that point, would be more appropriate.
Safety, recovery, and realistic expectations
Both treatments are injectable procedures and should be carried out only after appropriate assessment and consent. Temporary redness, swelling, tenderness, small raised injection points, and bruising can occur. These effects are usually short-lived, but recovery varies by treatment area and individual.
It is important to share relevant medical information, allergies, medicines, previous treatment reactions, and any current skin infection, irritation, or flare-up before proceeding. Product-specific suitability, contraindications, and potential risks should be discussed before treatment. For Redensity 1, these are set out in the manufacturer’s instructions for use.
Although uncommon, severe or increasing pain, blanching or unusual discolouration of the skin, or any visual disturbance after a facial injectable treatment requires urgent clinical assessment. Prompt communication with your practitioner is an important part of safe aftercare.
The key point
Polynucleotides and skin boosters both support skin quality, but their roles are different. Skin boosters are generally centred on hydration and visible freshness, while polynucleotides are used to support gradual improvement in skin texture and elasticity. The right choice is the one that matches your skin concerns, anatomy, medical history, and expectations following a personalised consultation.
Why Choose Clinic 22
Clinic 22 is a nurse-led medical aesthetics clinic in Kilmarnock and Saltcoats, where every treatment is planned with a focus on safety, suitability, and natural balance. All treatments are tailored following a detailed consultation, during which your facial structure, skin quality, medical history, and treatment goals are assessed to develop a plan specific to you.
